Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Patenting personalized medicines in the UK, Europe and USA.

Parker S, Hall B.

Pharm Pat Anal. 2014 Mar;3(2):163-9. doi: 10.4155/ppa.14.3. Review.

PMID:
24588593
2.

Does patent protection for personalized medicine still exist in the USA?

Ellis J.

Pharm Pat Anal. 2016;5(2):87-90. doi: 10.4155/ppa.15.46. Epub 2016 Feb 18. No abstract available.

PMID:
26889759
3.

Patent disclosure requirements for therapeutic antibody patents.

De Luca C, Trifonova A.

Expert Opin Ther Pat. 2017 Aug;27(8):867-875. doi: 10.1080/13543776.2017.1296950. Epub 2017 Mar 9. Review.

PMID:
28276280
4.

Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?

Komatani TS.

Pharm Pat Anal. 2015;4(5):357-62. doi: 10.4155/ppa.15.22. Epub 2015 Oct 9. No abstract available.

PMID:
26451906
6.

Genomic patenting and the utility requirement.

Calvert J.

New Genet Soc. 2004 Dec;23(3):301-12.

PMID:
15828153
7.

The transatlantic divide: how divisional and continuing patent application filing practice differs between the USA and Europe.

Nytko-Lutz E, Crease D.

Pharm Pat Anal. 2012 Jul;1(3):245-8. doi: 10.4155/ppa.12.36.

PMID:
24236836
8.

Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

Huys I, Van Overwalle G, Matthijs G.

Eur J Hum Genet. 2011 Oct;19(10):1104-7. doi: 10.1038/ejhg.2011.76. Epub 2011 Jun 8.

9.

Patenting of stem cells.

Williams G.

Regen Med. 2006 Sep;1(5):697-703.

PMID:
17465737
10.

Patentability of life and ethics.

Lenoir N.

C R Biol. 2003 Oct-Nov;326(10-11):1127-34.

PMID:
14744124
11.

[Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].

Jannuzzi AH, Vasconcellos AG, de Souza CG.

Cad Saude Publica. 2008 Jun;24(6):1205-18. Review. Portuguese.

12.

Does European patent law unfairly discriminate against medical devices as compared with pharmaceuticals?

Sterckx S.

Expert Opin Ther Pat. 2015;25(8):845-8. doi: 10.1517/13543776.2015.1038240. Epub 2015 Apr 20.

PMID:
25892308
13.

[Patent protection in modern medical technology].

Bosch M.

Biomed Tech (Berl). 2002;47 Suppl 1 Pt 2:686-7. German.

PMID:
12465274
14.

[The generic Research and Development possibilities after Hungary accessed th European Patent Convention].

Kelen A, Angyal N, Máthé Z, Bódis A, Hódi K.

Acta Pharm Hung. 2003;73(2):123-9. Hungarian.

PMID:
14702693
15.

A brief guide to understanding patentability and the meaning of patents.

Elliott GC.

Acad Med. 2002 Dec;77(12 Pt 2):1309-14. Review.

PMID:
12480641
16.

Ethical questions to ponder in the European stem cell patent debate.

Curley D, Sharples A.

J Biolaw Bus. 2006;9(3):12-6.

PMID:
17152135
17.

Are the UK courts clamping down on 'evergreening' strategies for the extension of patent protection?

Albutt J.

Pharm Pat Anal. 2015 Jan;4(1):1-3. doi: 10.4155/ppa.14.48. No abstract available.

PMID:
25565154
18.

The patent eligibility of personalized medicine technologies.

Octavio L.

J Leg Med. 2014;35(3):423-31. doi: 10.1080/01947648.2014.936264. No abstract available.

PMID:
25207631
19.

Patenting pharmaceuticals in China.

Han W, Luo J.

Pharm Pat Anal. 2016 Jul;5(4):249-59. doi: 10.4155/ppa-2016-0010. Epub 2016 Jun 24.

PMID:
27338759
20.

Supplemental Content

Support Center